Expression of Multidrug Resistance–Associated Proteins Predicts Prognosis in Childhood and Adult Acute Lymphoblastic Leukemia
Sabine Plasschaert(Princess Máxima Center), Edo Vellenga(University Medical Center Groningen), Dorina M. vander Kolk, Eveline S.J.M. de Bont(Hôpital Saint-Michel), Elisabeth G.E. de Vries(Karolinska University Hospital), Marike Boezen(University of Groningen), Simon Daenen, Willem A. Kamps(Pediatric Oncology Group), Klaas Nico Faber(University Medical Center Groningen)
Cited by 108
Related Papers
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599